The effect of rosiglitazone treatment on bone marrow and bone marrow cells
Phase of Trial: Phase II
Latest Information Update: 06 Nov 2012
At a glance
- Drugs Rosiglitazone (Primary)
- Indications Postmenopausal osteoporosis
- Focus Pharmacodynamics
- 26 Apr 2011 Actual end date (1 Nov 2009) added as reported by ClinicalTrials.gov.
- 22 Feb 2011 Status changed from active, no longer recruiting to completed.
- 19 Feb 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.